Considering vitamin D3's multifaceted roles in immune modulation, oxidative stress mitigation, and inflammation regulation, this study aims to evaluate its effects on serum CHI3L1 and oxidative stress parameters in MS patients. This evidence concerns the gene CHI3L1 and myeloid sarcoma.